mecwins. Innovation in nanomechanics for biotechbology

Detection of cancer using nanosensors

 Several media have echoed the studies of Dr. Javier Tamayo's group published recently in Nature Nanotechnology about detection of cancer biomarkers using nanomechanical sensors. Blood contains a range of protein biomarkers that could be used in the early detection of disease but to achieve this, ultra high sensitivity and reproducibility is a must.

P.M. Kosaka, V. Pini, J.J. Ruz, R. A. da Silva, M. Ujue-González, D. Ramos, M. Calleja y J. Tamayo. Detection of cancer biomarkers in serum by hybrid mechanical and optoplasmonic nanosensor. Nature Nanotechnology. Doi: 10.1038/nnano.2014.250

Read a selection of articles in media by clicking the following links (only Spanish):


Muy Interesante

Diario Médico

Europa Press

Cadena Ser





01 MECWINS 01 from Montserrat Calleja on Vimeo.


Mecwins is a newly established technological company with a strong focus on R&D. Our activity is highly driven by cutting-edge technology and frontline innovation.

Mecwins is developing Nanotechnologies to an advanced stage where they can be applied to diversified fields, from NEMS characterization to clinical analysis.

Enterprise Platform